Association analysis of the glutamic acid decarboxylase 2 and the glutamine synthetase genes (GAD2, GLUL) with schizophrenia

Psychiatric Genetics

Volumn 19, Issue 1, 2009, Pages 6-13

  Arai, Shinsaku ^a   Shibata, Hiroki ^a,e   Sakai, Mayumi ^a   Ninomiya, Hideaki ^b   Lwata, Nakao ^c   Ozaki, Norio ^d   Fukumaki, Yasuyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Fukuoka Prefectural Dazaifu Hospital Psychiatric Center   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e NONE   (Japan)

Author keywords

Association study; Glutamic acid decarboxylase 2 gene; Glutamine synthetase gene; Haplotype; Linkage disequilibrium; Multifactor dimensionality reduction; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

GLUTAMATE AMMONIA LIGASE; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; GLUTAMATE RECEPTOR 2; GLUTAMATE RECEPTOR 3; GLUTAMATE RECEPTOR 4; GLUTAMATE RECEPTOR 5; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 58849103423     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328311875d     Document Type: Article

References (38)

1. Addington AM, Gornick M, Duckworth J, Sporn A, Gogtay N, Bobb A, et al. (2005). GAD1 (2q31.1), which encodes glutamic acid decarboxylase (GAD67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss, Mot Psychiatry 10:581-588.
2. Akbarian S, Huang HS (2006). Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders. Brain Res Rev 52:293-304.
3. Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I (2001). Controlling the false discovery rate in behavior genetics research. Behav Brain Res 125: 279-284.
4. Bruneau EG, McCullumsmith RE, Haroutunian V, Davis KL, Meador-Woodruff JH (2005). Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophr Res 75:27-34.
5. De Luca V, Muglia P, Masellis M, Jane Dalton E, Wong GW, et al. (2004). Polymorphisms in glutamate decarboxylase genes: analysis in schizophrenia. Psychiatr Genet 14:39-42.
6. Deng X, Shibata H, Ninomiya H, Tashiro N, Iwata N, Ozaki N, et al. (2004). Association study of polymorphisms in the excitatory amino acid transporter 2 gene (SLC1A2) with schizophrenia. BMC Psychiatry 4:21.
7. Deng X, Shibata H, Takeuchi N, Rachi S, Sakai M, Ninomiya H, et al. (2007). Association study of polymorphisms in the glutamate transporter genes SLC1A1, SLC1A3, and SLC1A6 with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 144:271-278.
8. Deng X, Sagata N, Takeuchi N, Tnaka M, Ninomiya H, Iwata N, et al. (2008). Association study of polymorphisms in the neutral amino acid transporter genes SLC1A4, SLC1A5 and the glycine transporter genes SLC6A5, SLC6A9 with schizophrenia. BMC Psychiatry 8:58.
9. Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V (2004). GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. J Neurosci Res 76:581-592.
10. Fujii Y, Shibata H, Kikuta R, Makino C, Tani A, Hirata N, et al. (2003). Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr Genet 13:71-76.
11. Gao XM, Sakai K, Roberts RC, Conley RR, Dean B, Tamminga CA (2000). lonotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am J Psychiatry 157:1141-1149.
12. Gluck MR, Thomas RG, Davis KL, Haroutunian V (2002). Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 159:1165-1173.
13. Hahn LW, Ritchie MD, Moore JH (2003). Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376-382.
14. Heldt SA, Green A, Ressler KJ (2004). Prepulse inhibition deficits in GAD65 knockout mice and the effect of antipsychotic treatment. Neuropsychophar-macology 29:1610-1619.
15. Ikeda M, Ozaki N, Yamanouchi Y, Suzuki T, Kitajima T, Kinoshita Y, et al. (2007). No association between the glutamate decarboxylase 67 gene (GAD1) and schizophrenia in the Japanese population. Schizophr Res 91:22-26.
16. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
17. Joo A, Shibata H, Ninomiya H, Kawasaki H, Tashiro N, Fukumaki Y (2001). Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol Psychiatry 6:186-192.
18. Lahiri DK, Nurnberger Jl Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19:5444.
19. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug-sernyl. Am Med Assoc Arch Neurol Psychiatry 81:363-369.
20. Lundorf MD, Buttenschon HN, Foldager L, Blackwood DH, Muir WJ, Murray V, et al. (2005). Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 135:94-101.
21. Makino C, Fujii Y, Kikuta R, Hirata N, Tani A, Shibata A, et al. (2003). Positive association of the AMPA receptor subunit GluR4 gene (GRIA4) haplotype with schizophrenia: linkage disequilibrium mapping using SNPs evenly distributed across the gene region. Am J Med Genet B Neuropsychiatr Genet 116:17-22.
22. Makino C, Shibata H, Ninomiya H, Tashiro N, Fukumaki Y (2005). Identification of single-nucleotide polymorphisms in the human W-methyl-D-aspartate receptor subunit NR2D gene, GRIN2D, and association study with schizophrenia, Psychiatr Genet 15:215-221.
23. Meador-Woodruff JH, Healy DJ (2000). Glutamate receptor expression in schizophrenic brain. Brain Res Brain Res Rev 31:288-294.
24. Mohn AR, Gainetdinov RR, Caron MG, Koller BH (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
25. Ohashi J, Tokunaga K (2001). The power of genome-wide association studies of complex disease genes: statistical limitations of indirect approaches using SNP markers. J Hum Genet 46:478-482.
26. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Pari FF, et al. (2001). Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147.
27. Sham P (1998). Statistics in human genetics. New York: Oxford University Press.
28. Shibata H, Joo A, Fujii Y, Tani A, Makino C, Hirata N, et al. (2001). Association study of polymorphisms in the GluR5 kainate receptor gene (GRIK1) with schizophrenia. Psychiatr Genet 11:139-144.
29. Shibata H, Shibata A, Ninomiya H, Tashiro N, Fukumaki Y (2002). Association study of polymorphisms in the GluR6 kainate receptor gene (GRIK2) with schizophrenia. Psychiatry Res 113:59-67.
30. Shibata H, Aramaki T, Sakai M, Ninomiya H, Tashiro N, Iwata N, et al. (2006). Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia. Psychiatry Res 141:39-51.
31. Shibata H, Tani A, Chikuhara T, Kikuta R, Sakai M, Ninomiya H, et al. (2008). Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia Psychiatric Res (In press).
32. Straub RE, Lipska BK, Egan MF, Goldberg TE, Callicott JH, Mayhew MB, et al. (2007). Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol Psychiatry 12:854-869.
33. Takaki H, Kikuta R, Shibata H, Ninomiya H, Tashiro N, Fukumaki Y (2004). Positive associations of polymorphisms in the metabotropic glutamate receptor type 8 gene (GRM8) with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 128:6-14.
34. Tani A, Kikuta R, Itoh K, Joo A, Shibata H, Ninomiya H, et al. (2002). Polymorphism analysis of the upstream region of the human N-methyl-D- aspartate receptor subunit NR1 gene (GRIND: implications for schizophrenia. Schizophr Res 58:83-86.
35. Xie X, Ott J (1993). Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 53:1107.
36. Zavitsanou K, Ward PB, Huang XF (2002). Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia. Neuropsychopharmacology 27:826-833.
37. Zhang B, Yuan Y, Jia Y, Yu X, Xu Q, Shen Y, et al. (2005). An association study between polymorphisms in five genes in glutamate and GABA pathway and paranoid schizophrenia. Eur Psychiatry 20:45-49.
38. Zhao X, Qin S, Shi Y, Zhang A, Zhang J, Bian L, et al. (2007). Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray. Schizophr Res 93:374-384.